Infectious Diseases (except HIV/AIDS)

  1. Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy

    1. Erin K. McCreary
    2. Lara Lemon
    3. Christina Megli
    4. Amber Oakes
    5. Rachel L. Zapf
    6. Paula L. Kip
    7. Christopher W. Seymour

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Effectiveness of Primary and Booster COVID-19 mRNA Vaccination against Omicron Variant SARS-CoV-2 Infection in People with a Prior SARS-CoV-2 Infection

    1. Margaret L. Lind
    2. Alexander James Robertson
    3. Julio Silva
    4. Frederick Warner
    5. Andreas C. Coppi
    6. Nathan Price
    7. Chelsea Duckwall
    8. Peri Sosensky
    9. Erendira C. Di Giuseppe
    10. Ryan Borg
    11. Mariam O Fofana
    12. Otavio T. Ranzani
    13. Natalie E. Dean
    14. Jason R. Andrews
    15. Julio Croda
    16. Akiko Iwasaki
    17. Derek A.T. Cummings
    18. Albert I. Ko
    19. Matt DT Hitchings
    20. Wade L. Schulz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination

    1. Lidya Handayani Tjan
    2. Koichi Furukawa
    3. Yukiya Kurahashi
    4. Silvia Sutandhio
    5. Mitsuhiro Nishimura
    6. Jun Arii
    7. Yasuko Mori

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Validation of reduced S-gene target performance and failure for rapid surveillance of SARS-CoV-2 variants

    1. Cyndi Clark
    2. Joshua Schrecker
    3. Matthew Hardison
    4. Michael S. Taitel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study

    1. Soledad González
    2. Santiago Olszevicki
    3. Alejandra Gaiano
    4. Ana Nina Varela Baino
    5. Lorena Regairaz
    6. Martín Salazar
    7. Santiago Pesci
    8. Lupe Marín
    9. Verónica V. González Martínez
    10. Teresa Varela
    11. Leticia Ceriani
    12. Enio Garcia
    13. Nicolás Kreplak
    14. Alexia Navarro
    15. Elisa Estenssoro
    16. Franco Marsico

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. A mixed methods study evaluating acceptability of a daily COVID-19 testing regimen with a mobile-app connected, at-home, rapid antigen test: Implications for current and future pandemics

    1. Nadia Nguyen
    2. Benjamin Lane
    3. Sangwon Lee
    4. Sharon Lipsky Gorman
    5. Yumeng Wu
    6. Alicia Li
    7. Helen Lu
    8. Noemie Elhadad
    9. Michael Yin
    10. Kathrine Meyers

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial

    1. Dean Follmann
    2. Holly E. Janes
    3. Olive D. Buhule
    4. Honghong Zhou
    5. Bethany Girard
    6. Kristen Marks
    7. Karen Kotloff
    8. Michaël Desjardins
    9. Lawrence Corey
    10. Kathleen M. Neuzil
    11. Jacqueline M. Miller
    12. Hana M. El Sahly
    13. Lindsey R. Baden

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Coding long COVID: characterizing a new disease through an ICD-10 lens

    1. Emily R. Pfaff
    2. Charisse Madlock-Brown
    3. John M. Baratta
    4. Abhishek Bhatia
    5. Hannah Davis
    6. Andrew Girvin
    7. Elaine Hill
    8. Elizabeth Kelly
    9. Kristin Kostka
    10. Johanna Loomba
    11. Julie A. McMurry
    12. Rachel Wong
    13. Tellen D. Bennett
    14. Richard Moffitt
    15. Christopher G. Chute
    16. Melissa Haendel
    17. The N3C Consortium
    18. The RECOVER Consortium

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Changes of LipoxinA 4 Levels Following Early Hospital Management of Patients with Non-Severe COVID-19: A Pilot Study

    1. Farzaneh Jamali
    2. Bita Shahrami
    3. Amirmahdi Mojtahedzadeh
    4. Farhad Najmeddin
    5. Amir Ahmad Arabzadeh
    6. Azar Hadadi
    7. Mohammad Sharifzadeh
    8. Mojtaba Mojtahedzadeh

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Similar viral loads in Omicron infections regardless of vaccination status

    1. Yosuke Hirotsu
    2. Makoto Maejima
    3. Masahiro Shibusawa
    4. Yume Natori
    5. Yuki Nagakubo
    6. Kazuhiro Hosaka
    7. Hitomi Sueki
    8. Hitoshi Mochizuki
    9. Toshiharu Tsutsui
    10. Yumiko Kakizaki
    11. Yoshihiro Miyashita
    12. Masao Omata

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 169 of 716 Next